ANNE ANANGA: Open Payments
NPI 1740625433 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$602 in 17 payments from 11 companies in 2025. Trend: 2023 $115 · 2024 $147 · 2025 $602
Food & beverage: $602
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $138 |
| ABBVIE INC. | 2 | $106 |
| Gilead Sciences, Inc. | 3 | $75 |
| Dexcom, Inc. | 2 | $73 |
| GlaxoSmithKline, LLC. | 1 | $54 |
| Exact Sciences Corporation | 2 | $41 |
| ViiV Healthcare Company | 1 | $34 |
| Theratechnologies Inc. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, Dexcom G6 Transmitter, SHINGRIX, The Cologuard Plus Collection Kit, APRETUDE, EGRIFTA, CAPLYTA.
Industry payments across FL — which companies pay providers there.
